Fresenius Kabi recalls sodium chloride injections over latex concern

Fresenius Kabi USA voluntarily recalled 163 lots of sodium chloride injections last week, noting that the product contains latex despite an insert that states otherwise. The company’s recall includes 0.9% injections in 10 mL vials and 20 mL vials. The product insert and the tray label for both kinds of vials say that the products’ stoppers do not contain natural rubber latex. Fresenius Kabi notified distributors and customers by letter, telling them that the stoppers do contain natural rubber latex. Get the full story at our sister site, Drug Delivery Business News. The post Fresenius Kabi recalls sodium chloride injections over latex concern appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Recalls Wall Street Beat Fresenius Source Type: news